ICD-10 Code C86.0 | Extranodal NK/T-cell lymphoma, nasal type Symptoms, Diagnosis, Billing

Extranodal NK/T-cell lymphoma, nasal type is a rare and aggressive form of non-Hodgkin lymphoma characterized by the proliferation of natural killer (NK) cells. It primarily affects the nasal cavity and surrounding tissues, leading to significant morbidity. Accurate coding with ICD-10 Code C86.0 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code C86.0 for Extranodal NK/T-cell lymphoma, nasal type?

ICD-10 Code C86.0 represents Extranodal NK/T-cell lymphoma, nasal type, a malignancy arising from NK cells that typically presents with nasal obstruction, epistaxis, and facial swelling. This code should be used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.

ICD-10 Code C86.0 – Clinical Definition and Explanation of Extranodal NK/T-cell lymphoma, nasal type

Extranodal NK/T-cell lymphoma, nasal type is primarily associated with Epstein-Barr virus (EBV) infection and is characterized by aggressive behavior and a poor prognosis. It often requires prompt medical intervention due to its rapid progression and potential for systemic involvement.

Key Clinical Features:

• Commonly presents with nasal obstruction and epistaxis.
• Facial swelling and pain may occur due to local tissue infiltration.
• Associated with EBV, particularly in endemic cases.
• Higher prevalence in Asian populations, particularly males.

ICD-10 Code C86.0 for Extranodal NK/T-cell lymphoma, nasal type – SOAP Notes & Clinical Use

ICD-10 Code C86.0 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management.

What Does ICD-10 Code C86.0 for Extranodal NK/T-cell lymphoma, nasal type Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C86.0 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Extranodal NK/T-cell lymphoma, nasal type. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C86.0 – Extranodal NK/T-cell lymphoma, nasal type

Extranodal NK/T-cell lymphoma, nasal type requires urgent medical attention due to its aggressive nature. Treatment typically involves chemotherapy and may include radiation therapy.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Pain management with analgesics.
• Nutritional support to maintain strength.
• Psychosocial support for emotional well-being.

Infection Control:

• Standard precautions to prevent secondary infections.
• Monitoring for signs of opportunistic infections during treatment.

How to Document Symptoms of Extranodal NK/T-cell lymphoma, nasal type (ICD-10 C86.0) in SOAP Notes

Subjective:

• Patient reports nasal obstruction and frequent nosebleeds.
• Complains of facial swelling and pain in the nasal area.
• History of weight loss and fatigue over the past month.

Objective:

• Physical examination reveals nasal mass and erythema.
• CT scan shows soft tissue infiltration in the nasal cavity.
• Laboratory tests indicate elevated lactate dehydrogenase (LDH) levels.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Extranodal NK/T-cell lymphoma, nasal type (ICD-10 Code C86.0)

Assessment:

• Diagnosis: Extranodal NK/T-cell lymphoma, nasal type, aggressive.
• ICD-10 Code: C86.0.
• Contributing factors: EBV infection, male gender, Asian ethnicity.

Plan:

• Initiate chemotherapy regimen (e.g., CHOP or EPOCH).
• Consider radiation therapy for localized disease.
• Schedule follow-up imaging to assess treatment response.
• Provide patient education on disease and treatment options.

Treatment & Plan Section for ICD-10 Code C86.0 – Extranodal NK/T-cell lymphoma, nasal type

• First-line treatment typically includes combination chemotherapy.
• Supportive care measures to manage symptoms and side effects.
• Regular monitoring of blood counts and imaging studies.
• Patient education on recognizing signs of disease progression.

Using ICD-10 Code C86.0 for Extranodal NK/T-cell lymphoma, nasal type in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use C86.0 in appropriate clinical settings for billing purposes.
• Align treatment plans with clinical guidelines for reimbursement.
• Document any relevant comorbidities or complications.

Related ICD-10 Codes Often Used with Extranodal NK/T-cell lymphoma, nasal type

ICD-10 Code C86.0 in Medical Billing and Insurance for Extranodal NK/T-cell lymphoma, nasal type

ICD-10 Code C86.0 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use C86.0 in inpatient and outpatient settings as appropriate.
• Ensure that treatment plans are clearly outlined in the medical record.

Common CPT Pairings: